Raphaël Ognar

Raphaël Ognar is a Pharma/Biotech senior executive with expertise in Commercial & Strategic roles, including Cell Therapy, Immune-Oncology, and product lifecycle management in the Oncology/Hematology fields.

With 24 years of industry experience, including 19 years in Oncology and Hematology, Raphaël has a deep understanding of Global & Strategic Marketing, Operational Marketing, Corporate Strategy & Portfolio Management.

Passionate about fighting cancer and rare diseases, Raphaël continuously challenges himself to learn more and contribute to helping patients.

Key areas of expertise include Executive Management, Entrepreneurship, New Product Planning, Brand Management, Commercial and Development Strategy, Portfolio Management, P&L, Strategic Planning, and Oncology/Hematology Market.

Raphaël Ognar also excels in Cell Therapy, Immuno-Oncology, Personalized Medicine, Digital Health, AI integration, Real World Evidence, outcome analytics, and C-Suite Senior Leadership.

Education background includes DESS, DEA, Maitrise, and Licence degrees from Université de Bordeaux. Raphaël is the CEO & Co-Founder of NKILT Therapeutics and has held senior positions at Alira Health, ANIM8 LLC, Invectys Inc., and various other organizations.